| Michele Denise Corbitt, | |
|
1001 W Pratt St, Baltimore, MD 21223-2679 | |
| (443) 462-3407 | |
| Not Available |
| Full Name | Michele Denise Corbitt |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 1001 W Pratt St, Baltimore, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679339303 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LP46780 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michele Denise Corbitt, Po Box 62498, Baltimore, MD 21264-2498 Ph: () - | Michele Denise Corbitt, 1001 W Pratt St, Baltimore, MD 21223-2679 Ph: (443) 462-3407 |
News Archive
Upp Technology, a global provider of IT staffing services, implemented its irms|EM™ (Emergency Management) software for the State of Vermont within three weeks of selection of the solution. The software helped the State's RSS (Receive, Stage, & Store) Warehouse become operational following just one day of training and distribute more than 2,000 piece of H1N1 Personal Protection Equipment (PPE) inventory to hospitals throughout the state.
The U.S. Food and Drug Administration today approved Veltassa (patiromer for oral suspension) to treat hyperkalemia, a serious condition in which the amount of potassium in the blood is too high.
Developing new strategies to prevent and control yellow fever and dengue fever has become more possible with the completion of the first draft of the genome sequence of Aedes aegypti mosquito by scientists led by Vishvanath Nene at The Institute for Genomic Research (TIGR) and David Severson at the University of Notre Dame.
Angiogenesis is a common process that is essential for tumor growth beyond 2 mm. Although numerous growth factors are involved, vascular endothelial growth factor (VEGF), particularly VEGF-A, has been shown to play an important role in tumor angiogenesis.
Emerging therapies and promising new insights in the treatment of sickle cell disease represent a significant step toward improving outcomes and reducing the treatment burden for affected children and adults. Studies reporting these advances will be presented today at the 57th American Society of Hematology Annual Meeting and Exposition.
› Verified 8 days ago
Tamara Jean Riley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 111 Park Ave, Baltimore, MD 21201 Phone: 410-837-5533 Fax: 410-837-2168 | |
Jaleasa Cole, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1001 W Pratt St, Baltimore, MD 21223 Phone: 443-462-3407 | |
Jake John Carreon Cortes, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 821 N Eutaw St, Baltimore, MD 21201 Phone: 410-225-9185 | |
Sherlyn Sandy, MD Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4621 Arabia Ave, Baltimore, MD 21214 Phone: 443-413-8544 | |
Tayanna Gunn, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 821 N Eutaw St, Baltimore, MD 21201 Phone: 410-225-9185 | |
Mrs. Joann Newsom, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2433 Washington Blvd, Baltimore, MD 21230 Phone: 410-247-4034 | |
Mrs. Ayana Zeni Campbell, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3455 Wilkens Ave Lowr Level20, Baltimore, MD 21229 Phone: 410-646-6970 |